Cargando…
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients
The potential of the systemic antifungal treatment of non-immunocompromised patients with sepsis, extra-digestive Candida colonization and multiple organ failure is unknown, although it represents three out of four antifungal treatments prescribed in intensive care units. It may allow an early treat...
Autores principales: | Timsit, Jean-François, Chemam, Sarah, Bailly, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335794/ https://www.ncbi.nlm.nih.gov/pubmed/25750739 http://dx.doi.org/10.12703/P7-21 |
Ejemplares similares
-
Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species
por: Drgona, L., et al.
Publicado: (2013) -
Regional blocks for pre-emptive anti-emesis
por: Gupta, Deepak
Publicado: (2012) -
Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?
por: Golan, Yoav
Publicado: (2009) -
ICU Survivors Experience of ICU Diaries: An Ancillary Qualitative Analysis of the ICU Diary Study
por: Flahault, Cécile, et al.
Publicado: (2021) -
Determinants of mortality in non-neutropenic ICU patients with candidaemia
por: Marriott, Deborah JE, et al.
Publicado: (2009)